-+ 0.00%
-+ 0.00%
-+ 0.00%

LEADS BIOLABS AND DIANTHUS THERAPEUTICS ANNOUNCE INITIATION OF PHASE 1 TRIAL OF LBL-047 (DNTH212) IN HEALTHY VOLUNTEERS AND PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

路透·12/23/2025 11:00:27

登录查看新闻详情